| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 3333-3334 |
| Journal | Journal of Clinical Oncology |
| Volume | 29 |
| Issue number | 24 |
| DOIs | |
| Publication status | Published - 2011 |
Cite this
}
Is it pre-enucleation chemotherapy or delayed enucleation of severely involved eyes with intraocular retinoblastoma that risks extraocular dissemination and death? / Chantada, G.; Leal-Leal, C.; Brisse, H.; de Graaf, P.; Sitorus, R.S.; Qaddoumi, I.; de Antoneli, C.B.; Tacyildiz, N.; Fineman, S.L.; Lumbroso, L.; Doz, F.
In: Journal of Clinical Oncology, Vol. 29, No. 24, 2011, p. 3333-3334.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Is it pre-enucleation chemotherapy or delayed enucleation of severely involved eyes with intraocular retinoblastoma that risks extraocular dissemination and death?
AU - Chantada, G.
AU - Leal-Leal, C.
AU - Brisse, H.
AU - de Graaf, P.
AU - Sitorus, R.S.
AU - Qaddoumi, I.
AU - de Antoneli, C.B.
AU - Tacyildiz, N.
AU - Fineman, S.L.
AU - Lumbroso, L.
AU - Doz, F.
PY - 2011
Y1 - 2011
U2 - 10.1200/JCO.2011.35.9190
DO - 10.1200/JCO.2011.35.9190
M3 - Article
VL - 29
SP - 3333
EP - 3334
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
SN - 0732-183X
IS - 24
ER -